Predicting response to immunochemotherapy in EGFR-mutant lung adenocarcinoma after third-generation TKI resistance using CT radiomics-based habitat imaging - Quiz - MDSpire

Predicting response to immunochemotherapy in EGFR-mutant lung adenocarcinoma after third-generation TKI resistance using CT radiomics-based habitat imaging

  • By

  • Shuai Qie

  • Yasong Shi

  • Jingyun Li

  • Sicong Jia

  • Xiaoping Yin

  • June 2, 2026

Share

Original Source(s)

Predicting response to immunochemotherapy in EGFR-mutant lung adenocarcinoma after third-generation TKI resistance using CT radiomics-based habitat imaging

  • by Shuai Qie, Yasong Shi, Jingyun Li, Sicong Jia, Xiaoping Yin

  • June 2, 2026

Related Content

SEZ6-targeting antibody−drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial

Sustained complete response to TMEp-CI-M platform in refractory small-cell lung cancer with brainstem metastasis: a case report with over 20 months of disease-free survival

Editorial: Discovery of small molecule lead compounds: a driving force to unravel new anti-cancer targets and mechanisms, volume III